Incidence of genitourinary complications following radiation therapy for localised prostate cancer - Top-Institutions - MDSpire

Incidence of genitourinary complications following radiation therapy for localised prostate cancer

  • By

  • Rowan V. David

  • Arman A. Kahokehr

  • Jason Lee

  • David I. Watson

  • John Leung

  • Michael E. O’Callaghan

  • August 11, 2022

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Epidemiology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology

  • #3

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Radiation Oncology
    • Urology
    • Cancer Epidemiology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Radiation Oncology
    • Urology

  • #5

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, Victoria

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology

Original Source(s)

Incidence of genitourinary complications following radiation therapy for localised prostate cancer

  • by Rowan V. David, Arman A. Kahokehr, Jason Lee, David I. Watson, John Leung, Michael E. O’Callaghan

  • August 11, 2022

Related Content

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis

Evaluating the Role of PSMA-PET in Enhancing Salvage Radiotherapy: A Discussion on Precision versus Timing

Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy